Selinexor for myelofibrosis or a drug in search of a disease?
Selinexor for the Treatment of Myelofibrosis. SVR35- spleen volume reduction ≥ 35%, TSS- total symptom score.
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Nature Publishing Group
2026-07-01
|
| Cyfres: | Blood Cancer Journal |
| Mynediad Ar-lein: | https://doi.org/10.1038/s41408-026-01587-8 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|